BactiQuant A/S (9JX) Stock Statistics & Valuation Metrics
Total Valuation
BactiQuant A/S has a market cap or net worth of EUR 13.93M. The enterprise value is ―.
- Market Cap
- EUR 13.93M
- Enterprise Value
- ―
Share Statistics
BactiQuant A/S has 41,657,730 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 41,657,730
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
BactiQuant A/S’s return on equity (ROE) is -19.91 and return on invested capital (ROIC) is -110.16%.
- Return on Equity (ROE)
- -19.91
- Return on Assets (ROA)
- -0.93
- Return on Invested Capital (ROIC)
- -110.16%
- Return on Capital Employed (ROCE)
- -1.38
- Revenue Per Employee
- 597.93K
- Profits Per Employee
- -1.14M
- Employee Count
- 12
- Asset Turnover
- 0.49
- Inventory Turnover
- 4.32
Valuation Ratios
The current PE Ratio of BactiQuant A/S is -5.37. BactiQuant A/S’s PEG ratio is ―.
- PE Ratio
- -5.37
- PS Ratio
- 11.46
- PB Ratio
- 106.94
- Price to FCF
- -6.34
- Price to Operating Cash Flow
- -5.84
- PEG Ratio
- ―
Income Statement
In the last 12 months, BactiQuant A/S had revenue of 7.18M and earned -13.72M in profits. Earnings per share was -0.52.
- Revenue
- 7.18M
- Gross Profit
- -11.58M
- Operating Income
- -12.64M
- Pretax Income
- -13.72M
- Net Income
- -13.72M
- EBITDA
- -11.71M
- Earnings Per Share (EPS)
- -0.52
Cash Flow
In the last 12 months, operating cash flow was -10.01M and capital expenditures -623,167, giving a free cash flow of -10.64M billion.
- Operating Cash Flow
- -10.01M
- Free Cash Flow
- -10.64M
- Free Cash Flow per Share
- -0.49
Dividends & Yields
BactiQuant A/S pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -15.77%
- Earnings Yield
- -18.62%
Stock Price Statistics
- Beta
- -0.69
- 52-Week Price Change
- 20.16%
- 50-Day Moving Average
- 0.26
- 200-Day Moving Average
- 0.33
- Relative Strength Index (RSI)
- 64.96
- Average Volume (3m)
- ―
Financial Position
BactiQuant A/S as a current ratio of 1.56, with Debt / Equity ratio of 1565.19%
- Current Ratio
- 1.56
- Quick Ratio
- 0.77
- Debt to Market Cap
- 0.14
- Net Debt to EBITDA
- -0.85
- Interest Coverage Ratio
- -8.78
Taxes
In the past 12 months, BactiQuant A/S has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
BactiQuant A/S EV to EBITDA ratio is -7.87, with an EV/FCF ratio of -7.11.
- EV to Sales
- 12.85
- EV to EBITDA
- -7.87
- EV to Free Cash Flow
- -7.11
- EV to Operating Cash Flow
- -7.30
Balance Sheet
BactiQuant A/S has EUR 906.58K in cash and marketable securities with EUR 9.35M in debt, giving a net cash position of -EUR 8.44M billion.
- Cash & Marketable Securities
- EUR 906.58K
- Total Debt
- EUR 9.35M
- Net Cash
- -EUR 8.44M
- Net Cash Per Share
- -EUR 0.20
- Tangible Book Value Per Share
- EUR 0.10
Margins
Gross margin is -161.42%, with operating margin of -176.21%, and net profit margin of -191.25%.
- Gross Margin
- -161.42%
- Operating Margin
- -176.21%
- Pretax Margin
- -191.25%
- Net Profit Margin
- -191.25%
- EBITDA Margin
- -163.13%
- EBIT Margin
- -171.18%
Analyst Forecast
The average price target for BactiQuant A/S is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- 0
- Revenue Growth Forecast
- 15.24%
- EPS Growth Forecast
- 24.32%